Merck will partner with Chinese biotech Abbisko Therapeutics to market and sell the bone-tumor treatment pimicotinib globally, expanding its commercialization rights for the drug beyond Asia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback